Header Logo

Connection

William Hildebrand to Immunotherapy, Active

Back to Details
This is a "connection" page, showing publications William Hildebrand has written about Immunotherapy, Active.
William Hildebrand
Connection Strength
0.126
Immunotherapy, Active
  1. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348(6236):803-8.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.